Lenalidomide for the treatment of mantle cell lymphoma.
2019-01-01 Morabito, F; Skafi, M; Recchia, Ag; Kashkeesh, A; Hindiyeh, M; Sabatleen, A; Morabito, L; Alijanazreh, H; Hamamreh, Y; Gentile, M
Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study
2020-01-01 Cuneo, A; Mato, Ar; Rigolin, Gm; Piciocchi, A; Gentile, M; Laurenti, L; Allan, Jn; Pagel, Jm; Brander, Dm; Hill, Bt; Winter, A; Lamanna, N; Tam, Cs; Jacobs, R; Lansigan, F; Barr, Pm; Shadman, M; Skarbnik, Ap; Pu, Jj; Sehgal, Ar; Schuster, Sj; Shah, Nn; Ujjani, Cs; Roeker, L; Orlandi, Em; Billio, A; Trentin, L; Spacek, M; Marchetti, M; Tedeschi, A; Ilariucci, F; Gaidano, G; Doubek, M; Farina, L; Molica, S; Di Raimondo, F; Coscia, M; Mauro, Fr; de la Serna, J; Medina Perez, A; Ferrarini, I; Cimino, G; Cavallari, M; Cucci, R; Vignetti, M; Foà, R; Ghia, P; Gimema, ; European Research Initiative (ERIC) on, Cll; US study, Group.
Genetic Landscape of Ultra-Stable Chronic Lymphocytic Leukemia Patients.
2018-01-01 Raponi, S; Del Giudice, I; Marinelli, M; Wang, J; Cafforio, L; Ilari, C; Piciocchi, A; Messina, M; Bonina, S; Tavolaro, S; Bordyuh, M; Mariglia, P; Peragine, N; Mauro, Fr; Chiaretti, S; Molica, S; Gentile, M; Visentin, A; Trentin, L; Rigolin, Gm; Cuneo, A; Diop, F; Rossi, D; Gaidano, G; Guarini, A; Rabadan, R; Foà, R.
Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients
2016-01-01 Gentile, M; Shanafelt, Td; Rossi, D; Laurenti, L; Mauro, Fr; Molica, S; Cutrona, G; Uccello, G; Campanelli, M; Vigna, E; Tripepi, G; Chaffee, Kg; Parikh, Sa; Bossio, S; Recchia, Ag; Innocenti, I; Pasquale, R; Neri, A; Ferrarini, M; Gaidano, G; Foà, R; Morabito, F.
Serum levels of soluble calreticulin predict for time to first treatment in early chronic lymphocytic leukaemia
2016-01-01 Molica, S; Digiesi, G; D'Arena, G; Mirabelli, R; Antenucci, A; Conti, L; Gentile, M; Musto, P; Neri, A; Morabito, F.
Erythroid but not Cytogenetic Response in a 5q- Syndrome Case: a delayed effect of lenalidomide or a consequence of deferasirox treatment?
2014-01-01 Vigna, E; Recchia, Ag; Cuzzola, M; Morabito, L; Gentile, M; Morabito, F.
Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cells.
2008-01-01 Cutrona, G; Colombo, M; Matis, S; Fabbi, M; Spriano, M; Callea, V; Vigna, E; Gentile, M; Zupo, S; Chiorazzi, N; Morabito, F; Ferrarini, M.
An old drug with a new future: bendamustine in multiple myeloma
2013-01-01 Gentile, M; Recchia, Ag; Mazzone, C; Vigna, E; Martino, M; Morabito, L; Lucia, E; Bossio, S; De Stefano, L; Granata, T; Palummo, A; Morabito, F.
Prognostic relevance of in vitro response to cell stimulation via surface IgD in binet stage a CLL.
2010-01-01 Morabito, F; Cutrona, G; Gentile, M; Fabbi, M; Matis, S; Colombo, M; Reverberi, D; Megna, M; Spriano, M; Callea, V; Vigna, E; Rossi, E; Lucia, E; Festini, G; Zupo, S; Molica, S; Neri, A; Ferrarini, M.
Heterogeneous expression of the collagen receptor DDR1 in chronic lymphocytic leukaemia and correlation with progression.
2017-01-01 Barisione, G; Fabbi, M; Cutrona, G; De Cecco, L; Zupo, S; Leitinger, B; Gentile, M; Manzoni, M; Neri, A; Morabito, F; Ferrarini, M; Ferrini, S.
Hematogenous extramedullary relapse in multiple myeloma - a multicenter retrospective study in 127 patients.
2019-01-01 Avivi, I; Cohen, Yc; Suska, A; Shragai, T; Mikala, G; Garderet, L; Seny, Gm; Glickman, S; Jayabalan, Ds; Niesvizky, R; Gozzetti, A; Wiśniewska-Piąty, K; Waszczuk-Gajda, A; Usnarska-Zubkiewicz, L; Hus, I; Guzicka, R; Radocha, J; Milunovic, V; Davila, J; Gentile, M; Castillo, Jj; Jurczyszyn, A.
Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient.
2008-01-01 Gentile, M; Lucia, E; Iorio, C; Vigna, E; Mazzone, C; Morelli, R; Bisconte, Mg; Gentile, C; Morabito, F.
Dissecting the Biological Relevance and Clinical Impact of lncRNA MIAT in Multiple Myeloma
2021-01-01 Todoerti, Katia; Ronchetti, Domenica; Puccio, Noemi; Silvestris, Ilaria; Favasuli, Vanessa; Amodio, Nicola; Gentile, Massimo; Morabito, Fortunato; Neri, Antonino; Taiana, Elisa
Long-term molecular remission in Philadelphia-positive acute lymphoblastic leukemia elderly patient after dasatinib discontinuation.
2016-01-01 Vigna, E; Gentile, M; Giagnuolo, G; Recchia, Ag; Bossio, S; De Stefano, L; Morelli, R; Morabito, F.
Therapeutic approaches for newly diagnosed multiple myeloma patients in the era of novel drugs.
2010-01-01 Morabito, F; Gentile, M; Mazzone, C; Bringhen, S; Vigna, E; Lucia, E; Recchia, Ag; Raimondo, Fd; Musto, P; Palumbo, A.
Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompromised patients.
2010-01-01 Vigna, E; De Vivo, A; Gentile, M; Morelli, R; Lucia, E; Mazzone, C; Recchia, Ag; Vianelli, N; Morabito, F.
Combination of bendamustine and rituximab as frontline therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials
2016-01-01 Gentile, M; Katja, Zirlik; Stefania, Ciolli; Francesca R., Mauro; Nicola Di, Renzo; Lucia, Mastrullo; Francesco, Angrilli; Stefano, Molica; Giovanni, Tripepi; Annamaria, Giordano; Francesco Di, Raimondo; Carmine, Selleri; Marta, Coscia; Maurizio, Musso; Lorella, Orsucci; Donato, Mannina; Angela, Rago; Angela, Giannotta; Felicetto, Ferrara; Yair, Herishanu; Lev, Shvidel; Tamar, Tadmor; Ilaria, Scortechini; Fiorella, Ilariucci; Roberta, Murru; Attilio, Guarini; Gerardo, Musuraca; Giuseppe, Mineo; Iolanda, Vincelli; Annalisa, Arcari; Giuseppe, Tarantini; Giuseppe, Caparrotti; Annalisa, Chiarenza; Luciano, Levato; Maria Rosaria, Villa; Maria Rosaria De, Paolis; Pier Luigi, Zinzani; Aaron, Polliack; Fortunato Morabito., Eur Journ of Cancer 2016; 60:154-16, 5.
Biological and clinical relevance of quantitative global methylation of repetitive DNA sequences in chronic lymphocytic leukemia.
2011-01-01 Fabris, S; Bollati, V; Agnelli, L; Morabito, F; Motta, V; Cutrona, G; Matis, S; Grazia Recchia, A; Gigliotti, V; Gentile, M; Deliliers, Gl; Bertazzi, Pa; Ferrarini, M; Neri, A; Baccarelli, A.
Assessing time to first treatment in early chronic lymphocytic leukemia (CLL): a comparative performance analysis of five prognostic models with inclusion of CLL-international prognostic index (CLL-IPI)
2016-01-01 Molica, S; Giannarelli, D; Levato, L; Mirabelli, R; Gentile, M; Morabito, F.
A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia.
2019-01-01 Cohen, Ja; Rossi, Fm; Zucchetto, A; Bomben, R; Terzi-di-Bergamo, L; Rabe, Kg; Degan, M; Steffan, A; Polesel, J; Santinelli, E; Innocenti, I; Cutrona, G; D' Arena, G; Pozzato, G; Zaja, F; Chiarenza, A; Rossi, D; Di Raimondo, F; Laurenti, L; Gentile, M; Morabito, F; Neri, A; Ferrarini, M; Fegan, Cd; Pepper, Cj; Del Poeta, G; Parikh, Sa; Kay, Ne; Gattei, V.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Lenalidomide for the treatment of mantle cell lymphoma. | 1-gen-2019 | Morabito, F; Skafi, M; Recchia, Ag; Kashkeesh, A; Hindiyeh, M; Sabatleen, A; Morabito, L; Alijanazreh, H; Hamamreh, Y; Gentile, M | |
| Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study | 1-gen-2020 | Cuneo, A; Mato, Ar; Rigolin, Gm; Piciocchi, A; Gentile, M; Laurenti, L; Allan, Jn; Pagel, Jm; Brander, Dm; Hill, Bt; Winter, A; Lamanna, N; Tam, Cs; Jacobs, R; Lansigan, F; Barr, Pm; Shadman, M; Skarbnik, Ap; Pu, Jj; Sehgal, Ar; Schuster, Sj; Shah, Nn; Ujjani, Cs; Roeker, L; Orlandi, Em; Billio, A; Trentin, L; Spacek, M; Marchetti, M; Tedeschi, A; Ilariucci, F; Gaidano, G; Doubek, M; Farina, L; Molica, S; Di Raimondo, F; Coscia, M; Mauro, Fr; de la Serna, J; Medina Perez, A; Ferrarini, I; Cimino, G; Cavallari, M; Cucci, R; Vignetti, M; Foà, R; Ghia, P; Gimema, ; European Research Initiative (ERIC) on, Cll; US study, Group. | |
| Genetic Landscape of Ultra-Stable Chronic Lymphocytic Leukemia Patients. | 1-gen-2018 | Raponi, S; Del Giudice, I; Marinelli, M; Wang, J; Cafforio, L; Ilari, C; Piciocchi, A; Messina, M; Bonina, S; Tavolaro, S; Bordyuh, M; Mariglia, P; Peragine, N; Mauro, Fr; Chiaretti, S; Molica, S; Gentile, M; Visentin, A; Trentin, L; Rigolin, Gm; Cuneo, A; Diop, F; Rossi, D; Gaidano, G; Guarini, A; Rabadan, R; Foà, R. | |
| Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients | 1-gen-2016 | Gentile, M; Shanafelt, Td; Rossi, D; Laurenti, L; Mauro, Fr; Molica, S; Cutrona, G; Uccello, G; Campanelli, M; Vigna, E; Tripepi, G; Chaffee, Kg; Parikh, Sa; Bossio, S; Recchia, Ag; Innocenti, I; Pasquale, R; Neri, A; Ferrarini, M; Gaidano, G; Foà, R; Morabito, F. | |
| Serum levels of soluble calreticulin predict for time to first treatment in early chronic lymphocytic leukaemia | 1-gen-2016 | Molica, S; Digiesi, G; D'Arena, G; Mirabelli, R; Antenucci, A; Conti, L; Gentile, M; Musto, P; Neri, A; Morabito, F. | |
| Erythroid but not Cytogenetic Response in a 5q- Syndrome Case: a delayed effect of lenalidomide or a consequence of deferasirox treatment? | 1-gen-2014 | Vigna, E; Recchia, Ag; Cuzzola, M; Morabito, L; Gentile, M; Morabito, F. | |
| Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cells. | 1-gen-2008 | Cutrona, G; Colombo, M; Matis, S; Fabbi, M; Spriano, M; Callea, V; Vigna, E; Gentile, M; Zupo, S; Chiorazzi, N; Morabito, F; Ferrarini, M. | |
| An old drug with a new future: bendamustine in multiple myeloma | 1-gen-2013 | Gentile, M; Recchia, Ag; Mazzone, C; Vigna, E; Martino, M; Morabito, L; Lucia, E; Bossio, S; De Stefano, L; Granata, T; Palummo, A; Morabito, F. | |
| Prognostic relevance of in vitro response to cell stimulation via surface IgD in binet stage a CLL. | 1-gen-2010 | Morabito, F; Cutrona, G; Gentile, M; Fabbi, M; Matis, S; Colombo, M; Reverberi, D; Megna, M; Spriano, M; Callea, V; Vigna, E; Rossi, E; Lucia, E; Festini, G; Zupo, S; Molica, S; Neri, A; Ferrarini, M. | |
| Heterogeneous expression of the collagen receptor DDR1 in chronic lymphocytic leukaemia and correlation with progression. | 1-gen-2017 | Barisione, G; Fabbi, M; Cutrona, G; De Cecco, L; Zupo, S; Leitinger, B; Gentile, M; Manzoni, M; Neri, A; Morabito, F; Ferrarini, M; Ferrini, S. | |
| Hematogenous extramedullary relapse in multiple myeloma - a multicenter retrospective study in 127 patients. | 1-gen-2019 | Avivi, I; Cohen, Yc; Suska, A; Shragai, T; Mikala, G; Garderet, L; Seny, Gm; Glickman, S; Jayabalan, Ds; Niesvizky, R; Gozzetti, A; Wiśniewska-Piąty, K; Waszczuk-Gajda, A; Usnarska-Zubkiewicz, L; Hus, I; Guzicka, R; Radocha, J; Milunovic, V; Davila, J; Gentile, M; Castillo, Jj; Jurczyszyn, A. | |
| Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient. | 1-gen-2008 | Gentile, M; Lucia, E; Iorio, C; Vigna, E; Mazzone, C; Morelli, R; Bisconte, Mg; Gentile, C; Morabito, F. | |
| Dissecting the Biological Relevance and Clinical Impact of lncRNA MIAT in Multiple Myeloma | 1-gen-2021 | Todoerti, Katia; Ronchetti, Domenica; Puccio, Noemi; Silvestris, Ilaria; Favasuli, Vanessa; Amodio, Nicola; Gentile, Massimo; Morabito, Fortunato; Neri, Antonino; Taiana, Elisa | |
| Long-term molecular remission in Philadelphia-positive acute lymphoblastic leukemia elderly patient after dasatinib discontinuation. | 1-gen-2016 | Vigna, E; Gentile, M; Giagnuolo, G; Recchia, Ag; Bossio, S; De Stefano, L; Morelli, R; Morabito, F. | |
| Therapeutic approaches for newly diagnosed multiple myeloma patients in the era of novel drugs. | 1-gen-2010 | Morabito, F; Gentile, M; Mazzone, C; Bringhen, S; Vigna, E; Lucia, E; Recchia, Ag; Raimondo, Fd; Musto, P; Palumbo, A. | |
| Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompromised patients. | 1-gen-2010 | Vigna, E; De Vivo, A; Gentile, M; Morelli, R; Lucia, E; Mazzone, C; Recchia, Ag; Vianelli, N; Morabito, F. | |
| Combination of bendamustine and rituximab as frontline therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials | 1-gen-2016 | Gentile, M; Katja, Zirlik; Stefania, Ciolli; Francesca R., Mauro; Nicola Di, Renzo; Lucia, Mastrullo; Francesco, Angrilli; Stefano, Molica; Giovanni, Tripepi; Annamaria, Giordano; Francesco Di, Raimondo; Carmine, Selleri; Marta, Coscia; Maurizio, Musso; Lorella, Orsucci; Donato, Mannina; Angela, Rago; Angela, Giannotta; Felicetto, Ferrara; Yair, Herishanu; Lev, Shvidel; Tamar, Tadmor; Ilaria, Scortechini; Fiorella, Ilariucci; Roberta, Murru; Attilio, Guarini; Gerardo, Musuraca; Giuseppe, Mineo; Iolanda, Vincelli; Annalisa, Arcari; Giuseppe, Tarantini; Giuseppe, Caparrotti; Annalisa, Chiarenza; Luciano, Levato; Maria Rosaria, Villa; Maria Rosaria De, Paolis; Pier Luigi, Zinzani; Aaron, Polliack; Fortunato Morabito., Eur Journ of Cancer 2016; 60:154-16, 5. | |
| Biological and clinical relevance of quantitative global methylation of repetitive DNA sequences in chronic lymphocytic leukemia. | 1-gen-2011 | Fabris, S; Bollati, V; Agnelli, L; Morabito, F; Motta, V; Cutrona, G; Matis, S; Grazia Recchia, A; Gigliotti, V; Gentile, M; Deliliers, Gl; Bertazzi, Pa; Ferrarini, M; Neri, A; Baccarelli, A. | |
| Assessing time to first treatment in early chronic lymphocytic leukemia (CLL): a comparative performance analysis of five prognostic models with inclusion of CLL-international prognostic index (CLL-IPI) | 1-gen-2016 | Molica, S; Giannarelli, D; Levato, L; Mirabelli, R; Gentile, M; Morabito, F. | |
| A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia. | 1-gen-2019 | Cohen, Ja; Rossi, Fm; Zucchetto, A; Bomben, R; Terzi-di-Bergamo, L; Rabe, Kg; Degan, M; Steffan, A; Polesel, J; Santinelli, E; Innocenti, I; Cutrona, G; D' Arena, G; Pozzato, G; Zaja, F; Chiarenza, A; Rossi, D; Di Raimondo, F; Laurenti, L; Gentile, M; Morabito, F; Neri, A; Ferrarini, M; Fegan, Cd; Pepper, Cj; Del Poeta, G; Parikh, Sa; Kay, Ne; Gattei, V. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista40393
- 2 Contributo in Volume2
Data di pubblicazione
- In corso di stampa37
- 2020 - 202713195
- 2010 - 201915036
- 2000 - 20097892
- 1990 - 19993088
- 1980 - 19891038
- 1971 - 1979109
Editore
- Society for information display2
- TAYLOR & FRANCIS LTD, 4 PARK SQUA...2
- "Il pensiero scientifico" Editore1
- American Physical Society1
- Athens Institute for Education an...1
- Deputazione Storia Patria per la ...1
- Edizioni Scientifiche Calabresi1
- ELSEVIER SCIENCE BV, PO BOX 211, ...1
- ETS1
- Geological Society of America Spe...1
Rivista
- JOURNAL OF HIGH ENERGY PHYSICS498
- PHYSICS LETTERS. SECTION B469
- THE EUROPEAN PHYSICAL JOURNAL. C,...397
- PHYSICAL REVIEW LETTERS272
- MOLECULES176
- PHYSICAL REVIEW D173
- BOLLETTINO FILOSOFICO168
- INTERNATIONAL JOURNAL OF MOLECULA...166
- APPLIED SCIENCES164
- FILOLOGIA ANTICA E MODERNA151
Serie
- ATINER'S CONFERENCE PAPER SERIES1
- INTERNATIONAL REVIEW OF NEUROBIOLOGY1
Keyword
- Humans268
- COVID-19164
- Italy154
- Calabria113
- Hadron-Hadron Scattering111
- Female110
- High Energy Physics - Experiment106
- Palladium105
- Hadron-Hadron scattering (experim...95
- Carbonylation88
Lingua
- eng28604
- ita6840
- fre287
- spa245
- ger96
- grc23
- alb18
- por16
- tur12
- lat10
Accesso al fulltext
- no fulltext39866
- open457
- reserved44
- restricted21
- internalNetwork5
- embargoed1
- partially open1